I Will Choose Gene Therapy

1799 Words8 Pages
I will choose gene therapy for this assignment. According to Genetics Home reference (2015), “gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient’s cells instead of using drugs or surgery.” Gene therapy made many medical accomplishments in less than two decades (American Society of Gene & Cell Therapy, 2015). According to American Society of Gene &Cell Therapy (2015), “within this short time span, it has moved from the conceptual stage to technology development and laboratory research to clinical translational trials for a variety of deadly diseases.” For example, gene therapy used to cure chronic…show more content…
In a clinical trial conducted in the United States, the therapeutic gene was introduced into the liver of patients, who then acquired the ability to have normal blood clotting time.” Gene therapy also cured ADA-SCID disease which is known as bubble boy disease (American Society of Gene & Cell Therapy, 2015). ADA-SCID disease affects children who born without immune system (American Society of Gene & Cell Therapy, 2015). According to American Society of Gene & Cell Therapy (2015), “the therapeutic gene called ADA was introduced into the bone marrow cells of such patients in the laboratory, followed by transplantation of the genetically corrected cells back to the same patients. The immune system was reconstituted in all six treated patients without noticeable side effects, who now live normal lives with their families without the need for further treatment.” Gene therapy also cured several kinds of cancer, such as suicide gene therapy, oncolytic virotherapy, and anti-angiogenesis and therapeutic gene vaccines (American Society of Gene & Cell Therapy, 2015). According to American Society of Gene & Cell Therapy (2015), “two-thirds of all gene therapy trials are for cancer and many of these are entering the advanced stage, including a Phase III trial of Ad.p53 for head and neck cancer and two different Phase III gene vaccine trials for
Open Document